Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26


Prevalence and characteristics of vitamin or dietary supplement users in Lausanne, Switzerland: the CoLaus study.

Marques-Vidal P, Pécoud A, Hayoz D, Paccaud F, Mooser V, Waeber G, Vollenweider P.

Eur J Clin Nutr. 2009 Feb;63(2):273-81. Epub 2007 Oct 17.


Genetics of cardiovascular diseases: from single mutations to the whole genome.

Cambien F, Tiret L.

Circulation. 2007 Oct 9;116(15):1714-24. Review. No abstract available.


Genetic and phenotypic architecture of metabolic syndrome-associated components in dyslipidemic and normolipidemic subjects: the GEMS Study.

Stirnadel H, Lin X, Ling H, Song K, Barter P, Kesäniemi YA, Mahley R, McPherson R, Waeber G, Bersot T, Cohen J, Grundy S, Mitchell B, Mooser V, Waterworth D.

Atherosclerosis. 2008 Apr;197(2):868-76. Epub 2007 Sep 21.


Association of apolipoprotein E genotypes with lipid levels and coronary risk.

Bennet AM, Di Angelantonio E, Ye Z, Wensley F, Dahlin A, Ahlbom A, Keavney B, Collins R, Wiman B, de Faire U, Danesh J.

JAMA. 2007 Sep 19;298(11):1300-11. Review.


Genomewide association analysis of coronary artery disease.

Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, Mayer B, Dixon RJ, Meitinger T, Braund P, Wichmann HE, Barrett JH, König IR, Stevens SE, Szymczak S, Tregouet DA, Iles MM, Pahlke F, Pollard H, Lieb W, Cambien F, Fischer M, Ouwehand W, Blankenberg S, Balmforth AJ, Baessler A, Ball SG, Strom TM, Braenne I, Gieger C, Deloukas P, Tobin MD, Ziegler A, Thompson JR, Schunkert H; WTCCC and the Cardiogenics Consortium.

N Engl J Med. 2007 Aug 2;357(5):443-53. Epub 2007 Jul 18.


A new multipoint method for genome-wide association studies by imputation of genotypes.

Marchini J, Howie B, Myers S, McVean G, Donnelly P.

Nat Genet. 2007 Jul;39(7):906-13. Epub 2007 Jun 17.


A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21.

van Heel DA, Franke L, Hunt KA, Gwilliam R, Zhernakova A, Inouye M, Wapenaar MC, Barnardo MC, Bethel G, Holmes GK, Feighery C, Jewell D, Kelleher D, Kumar P, Travis S, Walters JR, Sanders DS, Howdle P, Swift J, Playford RJ, McLaren WM, Mearin ML, Mulder CJ, McManus R, McGinnis R, Cardon LR, Deloukas P, Wijmenga C.

Nat Genet. 2007 Jul;39(7):827-9. Epub 2007 Jun 10.


Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.

Wellcome Trust Case Control Consortium.

Nature. 2007 Jun 7;447(7145):661-78.


Replicating genotype-phenotype associations.

NCI-NHGRI Working Group on Replication in Association Studies, Chanock SJ, Manolio T, Boehnke M, Boerwinkle E, Hunter DJ, Thomas G, Hirschhorn JN, Abecasis G, Altshuler D, Bailey-Wilson JE, Brooks LD, Cardon LR, Daly M, Donnelly P, Fraumeni JF Jr, Freimer NB, Gerhard DS, Gunter C, Guttmacher AE, Guyer MS, Harris EL, Hoh J, Hoover R, Kong CA, Merikangas KR, Morton CC, Palmer LJ, Phimister EG, Rice JP, Roberts J, Rotimi C, Tucker MA, Vogan KJ, Wacholder S, Wijsman EM, Winn DM, Collins FS.

Nature. 2007 Jun 7;447(7145):655-60. No abstract available.


TCF7L2 polymorphisms modulate proinsulin levels and beta-cell function in a British Europid population.

Loos RJ, Franks PW, Francis RW, Barroso I, Gribble FM, Savage DB, Ong KK, O'Rahilly S, Wareham NJ.

Diabetes. 2007 Jul;56(7):1943-7. Epub 2007 Apr 6.


Molecular biology of PCSK9: its role in LDL metabolism.

Horton JD, Cohen JC, Hobbs HH.

Trends Biochem Sci. 2007 Feb;32(2):71-7. Epub 2007 Jan 9. Review.


Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk.

Humphries SE, Whittall RA, Hubbart CS, Maplebeck S, Cooper JA, Soutar AK, Naoumova R, Thompson GR, Seed M, Durrington PN, Miller JP, Betteridge DJ, Neil HA; Simon Broome Familial Hyperlipidaemia Register Group and Scientific Steering Committee.

J Med Genet. 2006 Dec;43(12):943-9. Erratum in: J Med Genet. 2009 Dec;46(12):861. J Med Genet. 2010 Dec;47(12):862.


Genetic susceptibility to myocardial infarction and coronary artery disease.

Topol EJ, Smith J, Plow EF, Wang QK.

Hum Mol Genet. 2006 Oct 15;15 Spec No 2:R117-23. Review.


A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol.

Kotowski IK, Pertsemlidis A, Luke A, Cooper RS, Vega GL, Cohen JC, Hobbs HH.

Am J Hum Genet. 2006 Mar;78(3):410-22. Epub 2006 Jan 20.


Nature's randomised trials.

Hingorani A, Humphries S.

Lancet. 2005 Dec 3;366(9501):1906-8. No abstract available.


Power tools for human genetics.

Kruglyak L.

Nat Genet. 2005 Dec;37(12):1299-300. No abstract available.


Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R; Cholesterol Treatment Trialists' (CTT) Collaborators.

Lancet. 2005 Oct 8;366(9493):1267-78. Epub 2005 Sep 27. Erratum in: Lancet. 2005 Oct 15-21;366(9494):1358. Lancet. 2008 Jun 21;371(9630):2084.


Genome-wide association studies for common diseases and complex traits.

Hirschhorn JN, Daly MJ.

Nat Rev Genet. 2005 Feb;6(2):95-108. Review.


Haploview: analysis and visualization of LD and haplotype maps.

Barrett JC, Fry B, Maller J, Daly MJ.

Bioinformatics. 2005 Jan 15;21(2):263-5. Epub 2004 Aug 5.


Monogenic hypercholesterolemia: new insights in pathogenesis and treatment.

Rader DJ, Cohen J, Hobbs HH.

J Clin Invest. 2003 Jun;111(12):1795-803. Review. No abstract available.

Supplemental Content

Support Center